If you've taken a Mounjaro double dose, what to do first is simple: the UK patient leaflet says to talk to your doctor immediately, and the NHS says to get urgent advice from NHS 111 if you've used more than your prescribed dose. Below: the possible effects, how double doses happen, how to prevent another and what to do about your next injection.

Mounjaro (tirzepatide) is a prescription-only medicine, and a prescriber decides whether it suits you. This is information only, not medical advice. It draws on the UK patient leaflet (revised August 2026), the Summary of Product Characteristics (SmPC), the pen's Instructions for Use and the NHS tirzepatide page; your own doctor or pharmacist comes first.

Key takeaway: If you've injected more Mounjaro than prescribed, talk to your doctor straight away or get urgent advice from NHS 111, and keep the pen and pack to show them. Let your prescriber decide your next dose; don't skip or add to it yourself. Too much may cause low blood sugar and sickness, and because tirzepatide stays in the body a long time, symptoms may need watching for a while.

Mounjaro double dose: what to do straight away

The leaflet's instruction is brief: talk to your doctor immediately. The NHS adds an urgent route, NHS 111 (online or by calling 111), because too much tirzepatide can sometimes be dangerous.

  • Get advice now. Don't wait to see whether you feel unwell first.
  • Keep the pen and pack to hand so you can read the strength off the label, and note when each injection went in.
  • If you're sent to A&E, the NHS says not to drive: ask someone to drive you, or ask for an ambulance. Bring the packet or leaflet, any remaining medicine and any other medicines you take.
  • Ask about your next injection while you're getting advice, and let your prescriber decide what happens to it.

What too much Mounjaro can do

The leaflet says too much may cause low blood sugar (hypoglycaemia) and can make you feel sick or be sick. The SmPC's overdose section, written for prescribers, mentions gut-related side effects including nausea, and adds:

  • there is no specific antidote;
  • treatment is supportive, guided by a person's symptoms;
  • observation and treatment may need to continue for a prolonged period, given tirzepatide's half-life of approximately 5 days.

That long half-life is what allows weekly dosing. Neither document says how long effects last after too much, so follow what your doctor or NHS 111 tells you to watch for.

Low blood sugar, and who the leaflet singles out

The overdose wording names low blood sugar without limiting it to anyone. Elsewhere, the leaflet ties that risk most closely to using Mounjaro with a sulphonylurea (another diabetes medicine) or insulin: your doctor may need to change those doses, and you should test your blood glucose as instructed. If you use either, say so when you get advice.

Its listed symptoms of low blood sugar are headache, drowsiness, weakness, dizziness, feeling hungry, confusion, irritability, fast heartbeat and sweating. Your doctor should tell you how to treat it, and the leaflet says to avoid driving or using machines if you get these signs.

Sickness, fluids and stomach pain

The leaflet warns that vomiting, nausea or diarrhoea can cause dehydration, which may reduce kidney function, so drink plenty of fluids. Stop using Mounjaro and get urgent medical help for severe, persistent stomach pain, with or without sickness: it could be acute pancreatitis. Our side effects page covers the main side effects; the full list is in section 4 of the leaflet. Suspected side effects can be reported through the MHRA Yellow Card scheme.

How a double dose usually happens

The pen gives one fixed dose each time, so too much means an extra injection or the wrong strength.

  • An extra injection in the same week. You can't remember whether you injected, or a helper doses you without knowing you already have. The leaflet's minimum of 3 days between doses comes in its advice on a late dose and on changing your injection day; it isn't a limit for extra doses. An injection on top of your weekly one is still more than prescribed.
  • Repeating a doubtful injection. The Instructions for Use say 0 in the dose window confirms the full dose. If it isn't showing, put the needle back in and finish without redialling; if you still doubt it, don't start over or repeat the injection. A drop on the needle tip afterwards is normal.
  • The wrong strength after a step-up. Every strength has its own pen delivering the same 0.6 ml, so the milligram amount depends on which pen you pick up. Step 2 of the Instructions for Use says not to use a pen whose strength doesn't match your prescription; our KwikPen guide shows the label and dose window.
  • Catching up. The leaflet says not to use a double dose to make up for a forgotten one; our missed dose guide explains the 4-day rule instead.

Habits that make a repeat less likely

  • One fixed day. The leaflet suggests the same day each week, ticked on the Instructions for Use or marked on a calendar. See choosing your injection day.
  • A log, filled in straight after. The Instructions for Use end with a medication calendar: your weekday plus four date boxes, one per dose. A phone note works too if it's always the same one; add the strength and site.
  • The label, every time. Check name, strength and expiry against your latest prescription before attaching a needle.
  • No mixing strengths. After a step-up, ask your pharmacist what to do with unused pens of your old strength; the leaflet says medicines you no longer use should not go in household waste or wastewater.
  • One record-keeper. If someone helps you inject, agree who logs each dose.

What about your next dose?

Neither the leaflet nor the SmPC says what to do with your next scheduled injection after too much, so ask your prescriber. Meanwhile:

  • Ask in good time. Aim to have your prescriber's answer before your next injection is due.
  • Don't change your dose yourself: the leaflet says not to unless your doctor tells you to.
  • Don't stop on your own without talking to your doctor.
  • Check your supply. Each KwikPen holds 4 doses, so an extra injection leaves the pen it came from one dose short. Don't use leftover medicine after the last dose; ask your prescriber about your next pen.

Our dosage page explains the weekly schedule, how to inject covers the pen routine, and the FAQ answers wider questions.

Frequently asked questions

Is an extra Mounjaro injection dangerous?

The NHS says to get medical advice if you use too much tirzepatide because it can sometimes be dangerous. The leaflet says too much may cause low blood sugar and can make you feel or be sick. Talk to your doctor straight away or contact NHS 111.

How long do the effects of too much Mounjaro last?

Neither the leaflet nor the SmPC gives a timetable. The SmPC says tirzepatide's half-life is approximately 5 days and that a prolonged period of observation and treatment may be needed after an overdose.

Should I skip my next dose after a double dose?

The leaflet doesn't say. Ask your prescriber before your next scheduled injection, and don't skip, add or change doses on your own.

I'm not sure my injection worked. Can I inject again?

No. If the dose window doesn't show 0, the Instructions for Use say to put the needle back in and finish without redialling. If you still doubt the dose went in, don't start over or repeat it; ask your pharmacist or prescriber.

What if I used a higher-strength pen by mistake?

That is more than your prescribed dose, so handle it the same way: talk to your doctor immediately or get urgent advice from NHS 111, and keep the pen to show them.

Sources

  1. electronic medicines compendium (emc). Mounjaro KwikPen — Patient Information Leaflet (sections 2 to 5; last revised August 2026). medicines.org.uk
  2. electronic medicines compendium (emc). Mounjaro KwikPen — Summary of Product Characteristics (sections 4.4, 4.9 and 5.2). medicines.org.uk
  3. electronic medicines compendium (emc). Mounjaro KwikPen — Instructions for Use (steps 2, 12 and 13, and the medication calendar; last revised July 2025). medicines.org.uk
  4. NHS. Tirzepatide (Mounjaro). nhs.uk
  5. MHRA. Yellow Card scheme. yellowcard.mhra.gov.uk

Related reading